Location History:
- Independence, KY (US) (2005)
- Taylor Mill, KY (US) (2004 - 2009)
Company Filing History:
Years Active: 2004-2009
Title: **Innovations by Steven Karl Laughlin: Pioneering Patents in Health Solutions**
Introduction
Steven Karl Laughlin, an accomplished inventor based in Taylor Mill, Kentucky, is recognized for his significant contributions to the fields of biochemistry and pharmacology. With a portfolio of four patents, Laughlin focuses on advanced solutions for treating conditions linked to inflammatory responses and metalloprotease activities within the body.
Latest Patents
Among his most recent patents is a groundbreaking invention titled “Bicyclic pyrazolone cytokine inhibitors.” This invention involves compounds known as 6,7-dihydro-5H-pyrazolo[1,2α]pyrazol-1-ones, which demonstrate the ability to inhibit the extracellular release of inflammatory cytokines, thereby addressing several human and higher mammalian disease states. The invention includes compositions that incorporate these active compounds along with methodologies to prevent or control the enzymes associated with these diseases.
Another significant patent is focused on “Heterocyclic side chain containing, n-substituted metalloprotease inhibitors.” This patent reveals compounds that effectively inhibit metalloproteases, enzymes often related to various pathological conditions characterized by their excessive activity. The described compounds not only showcase a highly specific structure but also include various derivatives, such as optical isomers and pharmaceutically acceptable salts. Furthermore, it highlights pharmaceutical compositions that comprise these inhibitors and the methods for treating metalloprotease-related conditions.
Career Highlights
Currently, Steven Karl Laughlin is affiliated with The Procter & Gamble Company, where he continues to innovate and push the boundaries of health-related inventions. His extensive work has contributed to enhancing therapeutic strategies that target significant health challenges.
Collaborations
Throughout his career, Laughlin has collaborated with notable peers, including Michael Philip Clark and Michael G. Natchus. These partnerships have fostered a creative environment conducive to the development of impactful health solutions and advancements in patentable technologies.
Conclusion
Steven Karl Laughlin’s inventive work demonstrates a commitment to improving health outcomes through innovative patent solutions. With his latest patents addressing crucial biomedical challenges, he continues to be a prominent figure in the field, influencing the future of therapeutic interventions and health advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.